ArticleAging2016

Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer.

Jian Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.